Trontinemab Shows Promise for Treatment of Alzheimer Disease in New Data at CTAD
Trontinemab showed a 92% reduction in amyloid plaques, according to new data from the Brainshuttle AD trial. The drug showed an ability to lower amyloid levels and…

Trontinemab showed a 92% reduction in amyloid plaques, according to new data from the Brainshuttle AD trial. The drug showed an ability to lower amyloid levels and…

When brain organoids were introduced roughly a decade ago, they were a scientific curiosity. The pea-sized blobs of brain tissue grown from stem cells mimicked parts of the human brain, giving researchers a 3D model to study, instead of the usual…

Positive psychology forms the backbone of wellbeing programmes around the world. Many people aiming to improve their mental health and live a good life are told to follow a programme of activities that focus on making an intentional effort to…

DEAR DR. ROACH: My husband and I are over 65. We got the respiratory syncytial virus (RSV) vaccinations two years ago. I’m reading mixed reports on how often we should be getting them. — N.W.
ANSWER: Along with influenza and COVID, RSV is yet…

Heart failure (HF) represents a severe manifestation or the terminal stage of various cardiac diseases, posing a significant threat to human health.1 In recent years, the prevalence of HF has continued to rise, driven by population…

Atrial fibrillation (AF) is an independent risk factor for stroke, heart failure, cardiovascular disease, and mortality. The EAST-AFNET 4 study demonstrated that rhythm control strategies offer the benefits of symptom relief,…

Obesity research often promises breakthroughs yet struggles to balance effectiveness with safety. Many weight loss approaches act on appetite or behavior, while metabolism remains harder to adjust without unwanted effects.
Scientists have long…